Precision medicine is transforming cancer care, but insurance denials are blocking access to biomarker testing for thousands ...

Men’s Health Network debuts “My Cancer, My Plan” Podcast to help men navigate diagnosis, treatment decisions, and ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

Understanding those genetic “errors” has become central to modern lung cancer care. Biomarker testing, sometimes called tumour or genomic testing, looks for the changes in a tumour’s DNA that drive ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment. SAN FRANCISCO, CA, UNITED STATES, January 8, 2026 ...

A panel held during the Institute for Value-Based Medicine event in Chicago on August 14, 2025, included discussions of access to biomarker testing and perioperative treatment in patients with ...

Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...

Biomarker tests analyze a patient's underlying biology to help clinicians diagnose disease, monitor progression and identify ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...

Biomarkers are measurable indicators that can be tested to reveal important details about a cancer. Information about these biomarkers can help guide the best treatment for you, predict your response ...

SAN FRANCISCO, CA, UNITED STATES, January 8, 2026 /EINPresswire.com/ — New global initiative urges patients and clinicians to wait for biomarker testing results ...